ID17052A - THERAPEUTIC ACID ACID DRIVINGS - Google Patents

THERAPEUTIC ACID ACID DRIVINGS

Info

Publication number
ID17052A
ID17052A IDP972092A ID972092A ID17052A ID 17052 A ID17052 A ID 17052A ID P972092 A IDP972092 A ID P972092A ID 972092 A ID972092 A ID 972092A ID 17052 A ID17052 A ID 17052A
Authority
ID
Indonesia
Prior art keywords
acid
drivings
therapeutic
therapeutic acid
acid acid
Prior art date
Application number
IDP972092A
Other languages
Indonesian (id)
Inventor
David George Allen
Colin David Eldred
Brian David Judkins
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID17052A publication Critical patent/ID17052A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP972092A 1996-06-21 1997-06-19 THERAPEUTIC ACID ACID DRIVINGS ID17052A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines

Publications (1)

Publication Number Publication Date
ID17052A true ID17052A (en) 1997-12-04

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972092A ID17052A (en) 1996-06-21 1997-06-19 THERAPEUTIC ACID ACID DRIVINGS

Country Status (17)

Country Link
EP (1) EP0912555A1 (en)
JP (1) JP2000512648A (en)
KR (1) KR20000022041A (en)
AP (1) AP9801417A0 (en)
AR (1) AR008245A1 (en)
AU (1) AU3261197A (en)
BR (1) BR9709930A (en)
CA (1) CA2258753A1 (en)
CZ (1) CZ424698A3 (en)
EA (1) EA199801015A1 (en)
ID (1) ID17052A (en)
IL (1) IL127464A0 (en)
IS (1) IS4924A (en)
NO (1) NO985974L (en)
PL (1) PL330797A1 (en)
TR (1) TR199802665T2 (en)
WO (1) WO1997049699A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7064215B2 (en) 2001-07-03 2006-06-20 Chiron Corporation Indazole benzimidazole compounds
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
KR20050101551A (en) 2003-02-14 2005-10-24 와이어쓰 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
AU2007235499A1 (en) 2006-04-05 2007-10-18 Wyeth Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
JP5208963B2 (en) 2007-01-10 2013-06-12 エフ.ホフマン−ラ ロシュ アーゲー Sulfonamide derivatives as chymase inhibitors
CN113655155A (en) * 2021-07-28 2021-11-16 任贤金 Method for measuring SPH3127 related substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
JPH07501063A (en) * 1991-11-14 1995-02-02 グラクソ、グループ、リミテッド Piperidine acetic acid derivatives as fibrinogen-dependent platelet aggregation inhibitors
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PL330797A1 (en) 1999-06-07
AR008245A1 (en) 1999-12-29
IL127464A0 (en) 1999-10-28
AU3261197A (en) 1998-01-14
NO985974L (en) 1999-02-17
CA2258753A1 (en) 1997-12-31
BR9709930A (en) 1999-08-10
CZ424698A3 (en) 1999-05-12
EP0912555A1 (en) 1999-05-06
WO1997049699A1 (en) 1997-12-31
EA199801015A1 (en) 1999-08-26
NO985974D0 (en) 1998-12-18
AP9801417A0 (en) 1998-12-31
TR199802665T2 (en) 1999-03-22
KR20000022041A (en) 2000-04-25
JP2000512648A (en) 2000-09-26
IS4924A (en) 1998-12-15

Similar Documents

Publication Publication Date Title
ID18063A (en) ARILSUFONILAMINO HYDROCSAMATE ACID DRIVINGS
ID22809A (en) ARILSULFONYL HYDROXICAMIC ACID DRIVINGS
ID22799A (en) ARILSULFONILAMINO HYDROCSAMATE ACID DRIVINGS
ID28699A (en) OXYSIIMINALALOIC ACID DRIVINGS
ID20807A (en) SULFONILAMINOKARBOKSILAT ACID
ID24376A (en) AMIDOKARBOKSILAT ACID ACIDES
ID26978A (en) AMINOMETYLCARBOXICATE ACID DRIVINGS
ID20809A (en) SUBSTITUTED DIAMINOCARBOXICATE ACID
FI973002L (en) Therapeutic compound - fatty acid conjugates
ID19511A (en) FENILAMINO SUBSTITUTED TRISICLIC DRIVINGS
ID24118A (en) COMBINED THERAPY
FI971279L (en) Drug
ID22053A (en) AMINOFOSFONATE ACID DURATION IN PHARMACEUTICAL PROPERTIES
FI961630A7 (en) Therapeutic substances
DE69606053D1 (en) MODIFIED FLUORSULFONIC ACID
DE59402189D1 (en) 2-keto-3-methyl-4-hydroxy-valeric acid
ID17416A (en) MAKING ACRYLIC ACID
NO983090D0 (en) Therapeutic compounds
NO991561L (en) 3-Alkoxyisoxazol-4-yl-substituted 2-aminocarboxylic acid compounds
ID17052A (en) THERAPEUTIC ACID ACID DRIVINGS
FI970195L (en) Trifluoromethylquinolinecarboxylic acid derivative
ID21355A (en) MAKING ADIPAT ACID
ID24413A (en) BIFENIL DRIVINGS AS MEDICINES
ID22212A (en) HYDROXIC ACID PLANTATIONS
ID17124A (en) SUBSTITUTED CARBOXICATE DRIVINGS